1Garcia-Tsai G. Current management of the complications of the cirrhosis and portal hypertension: variceal hemorrhage, ascites and . spontaneous bacterial peritonitis [ J]. Gastroenterology , 2001, 120: 726-748.
2D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators [J]. Hepatology , 2003, 38(3):599-612.
3Chalasani N, Kahi C, Francois F, et al . Improved patient survival after acute variceal bleeding: a multicenter, cohort study[J]. Am J Gastroenterol , 2003, 98(3):653-659.
8Bosch J, Abraldes JG, et al . Portal hypertension and gastrointestinal bleeding[J]. Semin Liver Dis , 2008, 28(1):3-25.
9Technology Assessment Committee, Croffie J, et al . Sclerosing agents for use in GI endoscopy[J]. Gastrointest Endosc , 2007, 66(1) : 1-6.
10Meirelles-Santos JO, Carvalho AF, Callejas-Neto F, et al . Absolute ethanol and 5% ethanolamine oleate are comparable for sclerotherapy of esophageal varices [J ]. Gastrointest Endosc , 2000, 51:573-576.
8Bambha K,Kim WR,Pedersen R,et al.Predictors of early rebleed-ing and mortality after acute variceal haemorrhage in patients withcirrhosis[J].Gut,2008,57(6):814-20.
9Altintas E,Sezgin O,Kaqar S,et al.Esophageal variceal ligationfor acute variceal bleeding:results of three years follow-up[J].Gastroenterol,2004,15(1):27-33.
10Mathur SK,Vora IM,Supe AN,et al.Morphological changes in e-sophagus following endoscopic sclerotherapy with 3%aqueousphenol[J].Indian J,Gastroenterol,1990,9:213-215.
